Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Marinus Pharma (MRNS) Misses Q4 EPS by 14c

March 7, 2023 4:20 PM EST

Marinus Pharma (NASDAQ: MRNS) reported Q4 EPS of ($0.76), $0.14 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $7.16 million versus the consensus estimate of $9.07 million.

Corporate Guidance

For the fiscal year 2023, the Company expects ZTALMY U.S. net product revenues of... More